Procaps Group Appoints Dr. Camilo Camacho as President of the Organization
Share: Senior Executive from Abbott Laboratories Latin American EPD Division to Accelerate Procaps Group's Rollout of Global Growth Initiatives & Strengthen Its Management Team Procaps Group Reports Unaudited First Quarter 2021 Net Revenues of $78.7 Million, a 33% Increase Versus the First Quarter of 2020 Procaps Group, a leading integrated international healthcare and pharmaceutical company, has appointed Dr. Camilo Camacho as President of the organization. Dr. Camacho has over 23 years of experience in the pharmaceutical industry in Latin America, with broad experience in marketing, sales,...
Source: benzinga.com